Henny Billett is a Hematology physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 200 publications with 4,809 citations (h-index 29); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Montefiore Medical Park
1575 Blondell Avenue
Bronx, NY 10461
Telephone
866-633-8255Registry record last updated 8 Jul 2007.
Clinical trials
- Safety and Efficacy of Apixaban in Severe Renal Impairment
Sponsor: Albert Einstein College of Medicine
- Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease
Sponsor: Albert Einstein College of Medicine
- Hematology Biobank: In Vitro Study of Blood Disorders
Sponsor: Albert Einstein College of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- New York Blood Center, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Factor Xa inhibitor48.5%Eliquis100%Part D≥14 patientsVitamin K antagonist31.8%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial
Journal of Thrombosis and Haemostasis
2024 - Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Annals of Internal Medicine
2023 - Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Bristol Research (University of Bristol)
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”